Woodline Partners LP Revolution Medicines, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

A detailed history of Woodline Partners LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 3,433,713 shares of RVMD stock, worth $149 Million. This represents 1.41% of its overall portfolio holdings.

Number of Shares
3,433,713
Previous 3,290,791 4.34%
Holding current value
$149 Million
Previous $128 Million 21.82%
% of portfolio
1.41%
Previous 1.28%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$36.92 - $47.94 $5.28 Million - $6.85 Million
142,922 Added 4.34%
3,433,713 $156 Million
Q2 2024

Aug 14, 2024
SELL
$30.14 - $40.68 $15.3 Million - $20.6 Million
-506,357 Reduced 13.34%
3,290,791 $128 Million
Q1 2024

May 15, 2024
BUY
$26.56 - $33.55 $22.2 Million - $28.1 Million
837,108 Added 28.28%
3,797,148 $122 Million
Q4 2023

Feb 14, 2024
SELL
$18.35 - $34.12 $3.4 Million - $6.33 Million
-185,405 Reduced 5.89%
2,960,040 $84.9 Million
Q3 2023

Nov 14, 2023
SELL
$25.17 - $35.05 $15.5 Million - $21.6 Million
-615,930 Reduced 16.38%
3,145,445 $87.1 Million
Q2 2023

Aug 14, 2023
BUY
$20.28 - $27.0 $6.86 Million - $9.14 Million
338,403 Added 9.89%
3,761,375 $101 Million
Q1 2023

May 15, 2023
BUY
$20.76 - $30.09 $61.7 Million - $89.5 Million
2,972,957 Added 660.64%
3,422,972 $74.1 Million
Q4 2022

Feb 14, 2023
SELL
$17.68 - $25.53 $2.01 Million - $2.91 Million
-113,866 Reduced 20.19%
450,015 $10.7 Million
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $5.24 Million - $7.8 Million
300,082 Added 113.75%
563,881 $11.1 Million
Q2 2022

Aug 15, 2022
SELL
$14.54 - $27.17 $30.1 Million - $56.2 Million
-2,067,596 Reduced 88.68%
263,799 $5.14 Million
Q1 2022

May 16, 2022
SELL
$17.31 - $26.4 $10.4 Million - $15.8 Million
-598,643 Reduced 20.43%
2,331,395 $59.5 Million
Q4 2021

Feb 14, 2022
BUY
$24.35 - $33.7 $50.2 Million - $69.4 Million
2,060,554 Added 236.99%
2,930,038 $73.7 Million
Q3 2021

Nov 15, 2021
BUY
$23.95 - $33.41 $428,513 - $597,771
17,892 Added 2.1%
869,484 $23.9 Million
Q2 2021

Aug 16, 2021
BUY
$29.0 - $47.44 $276,370 - $452,103
9,530 Added 1.13%
851,592 $27 Million
Q1 2021

May 17, 2021
BUY
$37.21 - $54.43 $1.3 Million - $1.9 Million
34,932 Added 4.33%
842,062 $38.6 Million
Q4 2020

Feb 16, 2021
BUY
$30.19 - $45.49 $23.5 Million - $35.4 Million
779,219 Added 2791.8%
807,130 $32 Million
Q3 2020

Nov 16, 2020
BUY
$22.61 - $34.8 $631,067 - $971,302
27,911 New
27,911 $971,000
Q2 2020

Aug 14, 2020
SELL
$19.65 - $39.34 $1.08 Million - $2.16 Million
-54,867 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$20.0 - $34.08 $1.1 Million - $1.87 Million
54,867 New
54,867 $1.2 Million

Others Institutions Holding RVMD

# of Institutions
266
Shares Held
161M
Call Options Held
260K
Put Options Held
620K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.8B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email